Policy toward second-generation antipsychotic drugs: a cautionary note.

Suppr

超能文献

作者信息

Frank Richard G

机构信息

Department of Health Care Policy, Harvard University, Boston, MA 02115, USA.

出版信息

Psychiatr Serv. 2008 May;59(5):521-2. doi: 10.1176/ps.2008.59.5.521.

DOI:10.1176/ps.2008.59.5.521

PMID:18451008

Abstract

摘要

相似文献

Policy toward second-generation antipsychotic drugs: a cautionary note.

Psychiatr Serv. 2008 May;59(5):521-2. doi: 10.1176/ps.2008.59.5.521.

Antipsychotic drugs: the costs and benefits.

Harv Ment Health Lett. 2007 Mar;23(9):5-6.

Cost-effectiveness measures, methods, and policy implications from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for schizophrenia.

J Clin Psychiatry. 2007 Feb;68(2):e05. doi: 10.4088/jcp.0207e05.

[Expensive but nevertheless cost effect? Pharmacoeconomics of atypical neuroleptics].

Pharm Unserer Zeit. 2002;31(6):572-6. doi: 10.1002/1615-1003(200211)31:6<572::AID-PAUZ572>3.0.CO;2-D.

Second-generation antipsychotics: cost-effectiveness, policy options, and political decision making.

Psychiatr Serv. 2008 May;59(5):515-20. doi: 10.1176/ps.2008.59.5.515.

Outcomes, costs, and policy caution. A commentary on: the Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

Arch Gen Psychiatry. 2006 Oct;63(10):1074-6. doi: 10.1001/archpsyc.63.10.1074.

Developing a policy for second-generation antipsychotic drugs.

Health Aff (Millwood). 2009 Sep-Oct;28(5):w782-93. doi: 10.1377/hlthaff.28.5.w782. Epub 2009 Jul 21.

Antipsychotic drugs and schizophrenia.

N Engl J Med. 2006 Jan 19;354(3):298-300; author reply 298-300.

Drug treatments for schizophrenia.

Qual Health Care. 2000 Mar;9(1):73-9. doi: 10.1136/qhc.9.1.73.

Cost-effectiveness of schizophrenia pharmacotherapy.

Am J Psychiatry. 2007 Apr;164(4):678; author reply 678-9. doi: 10.1176/ajp.2007.164.4.678a.

引用本文的文献

Improving quality and diffusing best practices: the case of schizophrenia.

Health Aff (Millwood). 2009 May-Jun;28(3):701-12. doi: 10.1377/hlthaff.28.3.701.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Policy toward second-generation antipsychotic drugs: a cautionary note.

Psychiatr Serv. 2008 May;59(5):521-2. doi: 10.1176/ps.2008.59.5.521.

Antipsychotic drugs: the costs and benefits.

Harv Ment Health Lett. 2007 Mar;23(9):5-6.

Cost-effectiveness measures, methods, and policy implications from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for schizophrenia.

J Clin Psychiatry. 2007 Feb;68(2):e05. doi: 10.4088/jcp.0207e05.

[Expensive but nevertheless cost effect? Pharmacoeconomics of atypical neuroleptics].

Pharm Unserer Zeit. 2002;31(6):572-6. doi: 10.1002/1615-1003(200211)31:6<572::AID-PAUZ572>3.0.CO;2-D.

Second-generation antipsychotics: cost-effectiveness, policy options, and political decision making.

Psychiatr Serv. 2008 May;59(5):515-20. doi: 10.1176/ps.2008.59.5.515.

Outcomes, costs, and policy caution. A commentary on: the Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

Arch Gen Psychiatry. 2006 Oct;63(10):1074-6. doi: 10.1001/archpsyc.63.10.1074.

Developing a policy for second-generation antipsychotic drugs.

Health Aff (Millwood). 2009 Sep-Oct;28(5):w782-93. doi: 10.1377/hlthaff.28.5.w782. Epub 2009 Jul 21.

Antipsychotic drugs and schizophrenia.

N Engl J Med. 2006 Jan 19;354(3):298-300; author reply 298-300.

Drug treatments for schizophrenia.

Qual Health Care. 2000 Mar;9(1):73-9. doi: 10.1136/qhc.9.1.73.

Cost-effectiveness of schizophrenia pharmacotherapy.

Am J Psychiatry. 2007 Apr;164(4):678; author reply 678-9. doi: 10.1176/ajp.2007.164.4.678a.

引用本文的文献

Improving quality and diffusing best practices: the case of schizophrenia.

Health Aff (Millwood). 2009 May-Jun;28(3):701-12. doi: 10.1377/hlthaff.28.3.701.